Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06551506
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-09
Brief Title:
The Immunology and Safety of Maternal RSV Vaccination ABRYSVO Infant Nirsevimab BEYFORTUS Immunization or Both Products
Sponsor:
Organization:
None